About this trial

Prediction and treatment of pediatric diseases and long-term outcomes through microbiome and multi-omics analysis by life cycle: We aim to demonstrate that a wide range of diseases are associated with gut microbiome dysbiosis and to investigate the subsequent recovery (restoration) or further deterioration of the gut microbiome over time. This study seeks to offer a novel perspective on changes in the gut microbiome, particularly in the context of the gut-lung and gut-brain axes.

Eligibility criteria

Qualifiers

children (including newborns) who have obtained their consent from their guardians

Disqualifiers

subjects who did not obtain consent

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
Hanyang University Medical Center04763, Seoul South Korea

Sponsors and collaborators

Hanyang University

Lead sponsor